Shopping Cart
- Remove All
- Your shopping cart is currently empty
Farletuzumab-MMAE, an antibody-drug conjugate (ADC), combines an FRA-targeted antibody with Monomethyl auristatin E (MMAE) and is utilized in researching non-small cell lung cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | Farletuzumab-MMAE, an antibody-drug conjugate (ADC), combines an FRA-targeted antibody with Monomethyl auristatin E (MMAE) and is utilized in researching non-small cell lung cancer. |
Molecular Weight | 150.62 kDa |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.